subject area of
- Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus Academic Article
- Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays Academic Article
- Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Academic Article
- Antiphospholipid antibodies and venous thromboembolism Academic Article
- Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus Academic Article
- Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Academic Article
- Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. Academic Article
- Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children Conference Paper
- Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state [see comments] Academic Article
- Lipoprotein(a): another risk factor for venous thrombosis? Academic Article
- Lupus Anticoagulant Testing Academic Article
- Neuropsychiatric Symptoms in Scleroderma Academic Article
- Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism Academic Article
- Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism Academic Article
- The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group. Academic Article